NCT06419634
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06419634
Title Study of BMS-986497 (ORM-6151) as a Monotherapy, in Double and Triple Combination With Azacitidine and Venetoclax in Participants With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Bristol-Myers Squibb
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ESP | CAN

Facility Status City State Zip Country Details
Local Institution - 0011 New Haven Connecticut 06510 United States Details
Local Institution - 0010 Chicago Illinois 60611 United States Details
Local Institution - 0014 Boston Massachusetts 02114 United States Details
Local Institution - 0013 St Louis Missouri 63108 United States Details
Local Institution - 0008 Hackensack New Jersey 07601 United States Details
Local Institution - 0006 Houston Texas 77030 United States Details
Local Institution - 0002 Toronto Ontario M5G 2M9 Canada Details
Local Institution - 0003 Montreal Quebec H3T 1E2 Canada Details
Local Institution - 0020 Barcelona Catalunya [Cataluña] 08036 Spain Details
Local Institution - 0023 Seville 41013 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field